Isamu Ishiwata
Overview
Explore the profile of Isamu Ishiwata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tanaka H, Hasegawa J, Katsuragi S, Tanaka K, Arakaki T, Nakamura M, et al.
Sci Rep
. 2023 Aug;
13(1):12918.
PMID: 37558813
This study aimed to clarify the relationship between maternal mortality and advanced maternal age in Japan and to provide useful information for future perinatal management. Maternal death rates by age...
12.
Hashii K, Hasegawa J, Yamashita T, Tanaka H, Sakurai A, Samura O, et al.
J Obstet Gynaecol Res
. 2023 Jun;
49(9):2252-2266.
PMID: 37381694
Here, we aimed to provide an overview of Japan Council for the Implementation of the Maternal Emergency Life-Saving System (J-CIMELS) and its simulation program, which has reduced maternal mortality due...
13.
Tanaka H, Hasegawa J, Katsuragi S, Tanaka K, Arakaki T, Nakamura M, et al.
J Clin Med
. 2023 Apr;
12(8).
PMID: 37109244
Background: Unlike Europe and the United States, Japan has seen numerous maternal deaths from hemorrhagic strokes related to hypertensive disorders of pregnancy (HDP). This study retrospectively analyzed deaths associated with...
14.
Matsushita T, Arakaki T, Sekizawa A, Hasegawa J, Tanaka H, Katsuragi S, et al.
J Matern Fetal Neonatal Med
. 2023 Feb;
36(1):2175207.
PMID: 36750232
Objective: Cardiovascular disease (CVD) is the leading cause of maternal deaths in high-income countries. This study aimed to assess the characteristics of maternal deaths due to CVDs and the quality...
15.
Arakaki T, Hasegawa J, Sekizawa A, Ikeda T, Ishiwata I, Kinoshita K
BMJ Open
. 2022 Dec;
12(12):e068575.
PMID: 36585128
Objective: To identify independent risk factors for severe COVID-19 in pregnant women and to evaluate the impact of disease severity on preterm birth. Design: A case-control study based on data...
16.
Hasegawa J, Tanaka H, Katsuragi S, Nii M, Sekizawa A, Ishiwata I, et al.
J Matern Fetal Neonatal Med
. 2022 Oct;
35(26):10451-10454.
PMID: 36195456
Serious group A streptococcal (GAS) infections and toxic shock syndrome (TSS) are rare conditions, but their rapid progression often results in death. The purpose of the present study was to...
17.
Clinical characteristics of pregnant women with COVID-19 in Japan: a nationwide questionnaire survey
Arakaki T, Hasegawa J, Sekizawa A, Ikeda T, Ishiwata I, Kinoshita K
BMC Pregnancy Childbirth
. 2021 Sep;
21(1):636.
PMID: 34536994
Background: Few reports have presented an overall view of pregnant women with coronavirus disease 2019 (COVID-19) across an entire country and throughout the entire gestation period. Furthermore, no such reports...
18.
Tanaka H, Katsuragi S, Hasegawa J, Tanaka K, Nakamura M, Hayata E, et al.
Brain Sci
. 2021 Aug;
11(8).
PMID: 34439614
Sudden unexpected death in epilepsy (SUDEP) is defined as the sudden death of a patient with epilepsy in the absence of an anatomic or toxicologic cause. Whether pregnancy is a...
19.
Hasegawa J, Arakaki T, Sekizawa A, Ikeda T, Ishiwata I, Kinoshita K
PLoS One
. 2021 May;
16(5):e0251434.
PMID: 34015017
A nationwide questionnaire survey about community-acquired infection of coronavirus disease 2019 (COVID-19) was conducted in July 2020 to identify the characteristics of and measures taken by Japanese medical facilities providing...
20.
Enomoto N, Tanaka H, Katsuragi S, Hayata E, Hasegawa J, Nakata M, et al.
J Obstet Gynaecol Res
. 2021 Apr;
47(6):2066-2075.
PMID: 33821513
Aim: The number of maternal deaths due to pregnancy-associated hemorrhagic stroke has not decreased despite a gradual decrease of maternal death in Japan. This study aimed to clarify the risk...